Search NLS News

LEO Pharma has appointed Brian Hilberdink new EVP and President of LEO Pharma Inc., in the United States, effective March 14, 2022. Brian Hilberdink joins LEO Pharma from Novo Nordisk, Inc., in the U.S. where he served as Senior Vice President of Sales. “We are excited to soon have an accomplished executive like Brian Hilberdink, […]

The US biotech company, focusing om messenger RNA therapeutics and vaccines, has announced plans to expand its commercial footprint in Europe across six additional countries. The announcement reinforces Moderna’s commitment to Europe and vision as a global commercial enterprise, building on the recent announcement of expansion in the Asia-Pacific region, it states in a press […]

Coripharma has secured equity funding to further support its future growth through research and development of generic pharmaceutical products in addition to increased commercial outreach. The financing round is in line with the company’s previously communicated plans and attracted significant interest from large institutional investors, including Icelandic pension funds, as well as receiving strong support […]

BerGenBio has announced the appointment of Anders Tullgren to succeed Sveinung Hole as Chairman of the Board of Directors. Sveinung Hole has been Chairman of the Board since March 2019 and will continue to serve as a Board Member. “We’re delighted to welcome Anders Tullgren as Chairman. Anders’ experience and deep knowledge of development, commercialization […]

Swedish researchers and doctors have successfully treated a child with neuroblastoma by using a tailored precision medicine approach. “Combining genetic mapping and biological understanding with a new targeted treatment is precision medicine made real, which can make a difference and cure more children who have cancer,” says co-last author Per Kogner (Karolinska Institutet/Astrid Lindgren Children’s […]

Jens Bukh has contributed to giving thousands of people a better and longer life through his research within hepatitis C. Jens Bukh heads the Copenhagen Hepatitis C Program at the Department of Infectious Diseases at Copenhagen University Hospital, Amager-Hvidovre and the Department of Immunology and Microbiology at the University of Copenhagen. Hepatitis C can be […]

The two companies receive a Eurostars R&D grant to deliver AId, a novel artificial intelligence-based tool for drug discovery. In a strategic partnership between Desupervised and Red Glead Discovery the companies have joined forces to create AI-based solutions enabling companies to reduce cost and time in small molecule drug research and development, they state. “While […]

Zerion Pharma has entered into a strategic partnership with Hovione to accelerate the commercialization of the Dispersome technology. Through their partnership, the two companies are offering pharma and biotech companies worldwide access to an innovative drug delivery platform combined with an unparalleled experience in formulation development, scale up and GMP manufacturing, they state. This combination […]

The two companies will partner to develop next-generation respiratory inhalers using the propellant HFO-1234ze. HFO-1234ze has up to 99.9% less Global Warming Potential (GWP) than propellants currently used in respiratory medicines, states AstraZeneca. “We are making great progress on our ambition to be zero carbon across our global operations by the end of 2025 and […]

An international team of scientist led by researchers from Karolinska Institutet shows that natural killer (NK) cells respond to a certain peptide on the surface of infected cells. The study, published in Cell Reports, is an important piece of the puzzle in our understanding of how the immune system reacts to COVID-19, state the researchers. […]